178 related articles for article (PubMed ID: 23326338)
1. Leuprorelin acetate long-lasting effects on GnRH receptors of prostate cancer cells: an atomic force microscopy study of agonist/receptor interaction.
Lama G; Papi M; Angelucci C; Maulucci G; Sica G; De Spirito M
PLoS One; 2013; 8(1):e52530. PubMed ID: 23326338
[TBL] [Abstract][Full Text] [Related]
2. GnRH receptor expression in human prostate cancer cells is affected by hormones and growth factors.
Angelucci C; Lama G; Iacopino F; Ferracuti S; Bono AV; Millar RP; Sica G
Endocrine; 2009 Aug; 36(1):87-97. PubMed ID: 19399647
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
Angelucci C; Iacopino F; Lama G; Capucci S; Zelano G; Boca M; Pistilli A; Sica G
Anticancer Res; 2004; 24(5A):2729-38. PubMed ID: 15517879
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoperone IN3 enhances the apoptotic effect of leuprolide in prostate cancer cells by increasing the gonadotropin-releasing hormone receptor in the cell membrane.
Sánchez CA; Mercado AJ; Contreras HR; Cabezas JC; Huidobro CC; Castellón EA
Anticancer Drugs; 2012 Oct; 23(9):959-69. PubMed ID: 22713594
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
[TBL] [Abstract][Full Text] [Related]
6. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
[TBL] [Abstract][Full Text] [Related]
7. Leuprorelin acetate affects ERK1/2 activity in prostate cancer cells.
Iacopino F; Lama G; Angelucci C; Sica G
Int J Oncol; 2006 Jul; 29(1):237-47. PubMed ID: 16773205
[TBL] [Abstract][Full Text] [Related]
8. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
[TBL] [Abstract][Full Text] [Related]
9. Leuprorelin acetate affects adhesion molecule expression in human prostate cancer cells.
Angelucci C; Lama G; Iacopino F; Sica G
Int J Oncol; 2011 Jun; 38(6):1501-9. PubMed ID: 21479359
[TBL] [Abstract][Full Text] [Related]
10. GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system.
Dondi D; Festuccia C; Piccolella M; Bologna M; Motta M
Oncol Rep; 2006 Feb; 15(2):393-400. PubMed ID: 16391860
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the GnRH type 1 receptor blocks the antiproliferative effect of the GnRH agonist, leuprolide, on the androgen-independent prostate cancer cell line DU145.
Ko YH; Ha YR; Kim JW; Kang SG; Jang HA; Kang SH; Park HS; Cheon J
J Int Med Res; 2011; 39(3):729-39. PubMed ID: 21819703
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.
Montagnani Marelli M; Moretti RM; Mai S; Procacci P; Limonta P
Int J Oncol; 2007 Jan; 30(1):261-71. PubMed ID: 17143537
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
[TBL] [Abstract][Full Text] [Related]
14. Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates.
Lau HL; Zhu XM; Leung PC; Chan LW; Chen GF; Chan PS; Yu KL; Chan FL
Int J Oncol; 2001 Dec; 19(6):1193-201. PubMed ID: 11713589
[TBL] [Abstract][Full Text] [Related]
15. The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist.
Taylor JE; Miller BT; Gray KD; Scott RT; Catherino WH; Segars JH
Fertil Steril; 2010 Mar; 93(5):1668-75. PubMed ID: 19200975
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancer.
Katsila T; Balafas E; Liapakis G; Limonta P; Montagnani Marelli M; Gkountelias K; Tselios T; Kostomitsopoulos N; Matsoukas J; Tamvakopoulos C
J Pharmacol Exp Ther; 2011 Mar; 336(3):613-23. PubMed ID: 21106905
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone receptor concentration differentially regulates intracellular signaling pathways in GGH3 cells.
Pinter JH; Janovick JA; Conn PM
Pituitary; 1999 Nov; 2(3):181-90. PubMed ID: 11081152
[TBL] [Abstract][Full Text] [Related]
18. In search of the molecular mechanisms mediating the inhibitory effect of the GnRH antagonist degarelix on human prostate cell growth.
Sakai M; Martinez-Arguelles DB; Patterson NH; Chaurand P; Papadopoulos V
PLoS One; 2015; 10(3):e0120670. PubMed ID: 25811175
[TBL] [Abstract][Full Text] [Related]
19. Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable "click" oxime bond tethers and preclinical evaluation against prostate cancer.
Vrettos EI; Karampelas T; Sayyad N; Kougioumtzi A; Syed N; Crook T; Murphy C; Tamvakopoulos C; Tzakos AG
Eur J Med Chem; 2021 Feb; 211():113018. PubMed ID: 33223264
[TBL] [Abstract][Full Text] [Related]
20. Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells.
Bahk JY; Hyun JS; Lee H; Kim MO; Cho GJ; Lee BH; Choi WS
Urol Res; 1998; 26(4):259-64. PubMed ID: 9759999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
